Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.08 USD | -1.28% | -5.43% | -8.85% |
05-17 | Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing | MT |
05-16 | Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.85% | 4.39B | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- NUVL Stock
- News Nuvalent, Inc.
- Nuvalent Appoints Mersana Therapeutics Chief Executive Anna Protopapas as Board Chair